Logo Logo
Hilfe
Hilfe
Switch Language to English

Lin, S.-S.; Zhang, R.-Q.; Shen, L.; Xu, X.-J.; Li, K.; Bazhin, A.-V.; Fichna, J. und Li, Y.-Y. (2018): Alterations in the gut barrier and involvement of Toll-like receptor 4 in murine postoperative ileus. In: Neurogastroenterology and Motility, Bd. 30, Nr. 6, e13286

Volltext auf 'Open Access LMU' nicht verfügbar.

Abstract

Background: The changes in the gut barrier (GB) and associated mechanisms in postoperative ileus (POI) are still unclear. Toll-like receptor 4 (TLR4) is involved in inflammation, which may cause GB dysfunction and POI. Here, the roles of the GB in POI in relation to TLR4-dependent signaling pathways were explored. Methods: POI was induced by small bowel manipulation in wild-type (WT) and TLR4-knockout (TLR4-/-) mice. Twenty-four hours after manipulation, indices of gastrointestinal (GI) transit, GB structure and function, inflammation, and related signaling pathways were analyzed. Key Results: Normal GI motility and GB function were not affected by TLR4 knockout. Compared with WT POI mice, TLR4-/-POI mice showed milder GI transit retardation, GB dysfunction, and inflammatory responses. In WT mice, GB disorder was characterized by colonic goblet cells depletion, increased gut claudin-2 expression, and decreased CD4+/CD8+ ratios in intestinal Peyer's patches. Green fluorescent protein-tagged Escherichia coli in the gut was detected in plasma and extraintestinal organs, followed with increased plasma lipopolysaccharide. These changes displayed in WT POI mice were less severe in TLR4-/-POI mice. Furthermore, the mRNA and protein expression of interleukin-6, monocyte chemotactic protein-1, pp38 and pJNK in the intestine, and TNF- level in plasma were significantly increased in WT, but not TLR4-/-POI mice. Conclusions & InferencesThese results indicate that GB is impaired in the experimental POI, with inflammation being involved in this pathological process. TLR4 deficiency alleviated GB dysfunction and suppressed inflammation by disrupting the activation of mitogen-activated protein kinase signaling pathways, thereby ameliorating POI.

Dokument bearbeiten Dokument bearbeiten